- Applied Clinical Trials-03-01-2024
- Volume 33
- Issue 3
A Need for Action
What are the necessary next steps—for all parties involved—in improving diversity in clinical trials?
In recent years, Applied Clinical Trials has featured an issue theme in its editorial calendar solely focused on diversity in clinical trials. The topic coverage typically constitutes one of our most well-read editions of the magazine, along with its companion online focus category
Notably, in a recent
To that end, our March feature coverage begins with an
Our
We are also happy to share new content from the recent Summit for Clinical Ops Executives (SCOPE) conference. Our editors on-site and back at home provided coverage of breakout sessions and conducted on-site interviews with key opinion leaders. Full coverage can be found at
As always, thank you for reading.
Mike Hennessy Jr, president and CEO, MJH Life Sciences®
Articles in this issue
over 1 year ago
New Legislation is Driving Diversity in Clinical Researchover 1 year ago
Seeking Solutions for More Representative Populationsover 1 year ago
The Missing Puzzle Pieces to Trial Representativenessover 1 year ago
eCOA Libraries: An Untapped Opportunity?over 1 year ago
Calling Out ‘Check-the-Box’ Patient Engagementover 1 year ago
Beyond the Iron Triangle: Behavioral Science Strategiesover 1 year ago
Changing the Face—and Faces—of Clinical Researchover 1 year ago
Diversity in Clinical Trials: Strategies and ChallengesNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.